| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157048 | American Journal of Kidney Diseases | 2016 | 12 Pages |
Abstract
Results suggest that once-daily LCPT in de novo kidney transplantation has comparable efficacy and safety profile to that of IR-Tac. Lower TDD reflects LCPT's improved bioavailability and absorption.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Lionel MD, PhD, Suphamai MD, Josep M. MD, Kazimierz MD, PhD, Jason E. MD, Helio Tedesco MD, Klemens MD,